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Background: Inflammation and oxidative stress are key factors in the pathogenesis of non-alcoholic 
steatohepatitis (NASH). Polymorphonuclear neutrophils are capable to produce significant amounts 
of reactive oxygen species (ROS) via the NADPH oxidase complex. Increased hepatic neutrophil 
infiltration has been described in steatohepatitis. We aimed to investigate the in vitro ROS 
generation by neutrophils of NASH patients and the hepatic NADPH oxidase activity in murine 
steatohepatitis. 
 
Material and methods: PMNs were isolated from peripheral blood of NASH patients (n=16) and 
healthy controls (n=16). In vitro ROS production was measured by luminol chemiluminescence after 
phorbol myristate acetate (PMA) or opsonized zymosan stimulation.  Hepatic lipid peroxidation and 
NADPH oxidase activation were measured in mice fed with methionine-choline-deficient (MCD) or -
supplemented (MCS) diets. 
 
Results: PMA activated oxidative burst both in patients and controls. However, ROS production was 
significantly increased in non-diabetic NASH patients (n=9) compared to controls 30 min after the 
PMA stimulation. PMNs from NASH patients with diabetes mellitus (n=7) did not have higher ROS 
production after PMA-stimulation compared to controls.  The PMA-induced peak 
chemiluminescence was significantly higher in the non-diabetic NASH patients compared to controls 
and diabetic NASH patients. No significant difference was observed without any stimulation and in 
opsonized zymosan induced chemiluminescence. Consistent with the increased oxidative capacity of 
PMNs in NASH patients, we found increased hepatic lipid peroxidation, higher expression and 
activation of the NADPH oxidase complex in MCD-steatohepatitis. 
 
Conclusion: Our finding supports the role of neutrophil oxidative stress in NASH. Our novel data 
suggests that the increased oxidative capacity of the PMNs it is not only localized to the liver but can 
have systemic effects and serve as a potential biomarker of NASH.    
 
